Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

44.1K
Overview
44.1K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Cancer Vaccines01:30

Cancer Vaccines

1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Vaccines01:21

Vaccines

98
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
98

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi-parent mapping reveals epistatic architecture and elite haplotypes for multi-trait improvement in cotton.

Genome biology·2026
Same author

GPR75 knockdown alleviates mitochondrial dysfunction in retinal ganglion cells via AMPK pathway in diabetic mice.

Biochemical pharmacology·2026
Same author

Principal stratification with U-statistics under principal ignorability.

Journal of the Royal Statistical Society. Series B, Statistical methodology·2026
Same author

Trends of autoimmune diseases in men and inequities in healthcare access and quality in young, working and postworking individuals: a global analysis of 32-year epidemiological study.

BMJ public health·2026
Same author

Multi-omics analysis reveals the regulatory network of quality traits in green-skinned eggplant (Solanum melongena L.).

Food chemistry·2026
Same author

CpG 1018 augments mRNA vaccine-induced anti-tumor immunity by potentiating CD8+ T cell responses.

Molecular therapy. Oncology·2026

Related Experiment Video

Updated: May 4, 2026

Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

22.5K

Laser vaccine adjuvant for cutaneous immunization.

Xinyuan Chen1, Mei X Wu

  • 1Wellman Center for Photomedicine and Department of Dermatology at Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Expert Review of Vaccines
|October 13, 2011
PubMed
Summary

A novel laser vaccine adjuvant offers a safe and effective method for cutaneous immunization. This non-inflammatory approach enhances immune cell activity, proving ideal for intradermal vaccination strategies.

More Related Videos

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

7.6K
Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation
07:04

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation

Published on: September 16, 2018

9.2K

Related Experiment Videos

Last Updated: May 4, 2026

Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

22.5K
Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

7.6K
Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation
07:04

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation

Published on: September 16, 2018

9.2K

Area of Science:

  • Immunology
  • Vaccinology
  • Biotechnology

Background:

  • Intradermal immunization technologies are advancing, necessitating new adjuvant options.
  • Traditional adjuvants may cause excessive skin inflammation, unsuitable for cutaneous delivery.
  • A need exists for safe, potent adjuvants for skin-based vaccination.

Purpose of the Study:

  • To introduce and evaluate the laser vaccine adjuvant for cutaneous immunization.
  • To assess the safety and efficacy of laser-induced adjuvant effects.
  • To explore advantages over conventional vaccine adjuvants.

Main Methods:

  • Inducing laser vaccine adjuvant via brief, noninvasive laser illumination of the skin.
  • Administering intradermal vaccine injection at the illuminated site.
  • Assessing immune responses, focusing on antigen-presenting cell motility.
  • Evaluating skin inflammation and reactogenicity.

Main Results:

  • Laser vaccine adjuvant effectively boosts immune responses.
  • The method does not induce significant skin inflammation or reactogenicity.
  • Enhanced motility of antigen-presenting cells was observed.
  • Laser adjuvant is safe and convenient for intradermal vaccination.

Conclusions:

  • Laser vaccine adjuvant is a safe and potent option for cutaneous immunization.
  • It offers advantages over traditional adjuvants, especially during vaccine shortages.
  • This technology is ideal for augmenting intradermal vaccination strategies.